Related Experiment Video

Updated: Apr 5, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

4.4K

Asymmetric vs Symmetric Treatment in Retinopathy of Prematurity

Francisco Altamirano1, Sandra Hoyek2, Melissa Yuan3

  • 1Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Ophthalmology
|April 4, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Retinopathy of prematurityasymmetric ROP treatmentsequential ROP treatmenttreatment-warranted retinopathy of prematurityunilateral ROP treatment

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

9.5K
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K

Related Experiment Videos

Last Updated: Apr 5, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

4.4K
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

9.5K
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

Articles linked to this work by shared authors, journal, and citation graph.

Adjunct 0.025% Povidone-Iodine Irrigation at Time of Vitrectomy for Management of Infectious Endophthalmitis: A Multicenter Single-Intervention Study.

Retina (Philadelphia, Pa.)·2026

Aggressive retinopathy of prematurity: characteristics and risk factors for retreatment.

The British journal of ophthalmology·2026

Retinopathy in Dyskeratosis Congenita and Related Telomere Biology Disorders: Short Telomere Associated Retinopathy (STAR).

Ophthalmology. Retina·2026

Observation Without Vitrectomy in Penetrating Open-Globe Injury With Retinal Strike Sites in Young Patients.

Ophthalmic surgery, lasers & imaging retina·2026

Systemic Interleukin-6 Inhibition and Risk of Diabetic Retinopathy Development and Progression.

Ophthalmology·2026

Late Retinal Detachments in Retinopathy of Prematurity.

Ophthalmic surgery, lasers & imaging retina·2026

Centralized Multidisciplinary Retinoblastoma Care Closes the Outcome Gap: Survival and Globe Salvage for 1000 Eyes from 601 Patients.

Ophthalmology·2026

Biologic Switching Strategies for Anti-Tumor Necrosis Factor Alpha Refractory Noninfectious Uveitis:: Systematic Review and Meta-Analysis of Clinical Approach.

Ophthalmology·2026

Association of Common Anti-Inflammatory Medications with Reduced Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes.

Ophthalmology·2026

Racial and Ethnic Disparities in Retinal Care Access and Experience.

Ophthalmology·2026

Efficacy and Safety of Satralizumab for Thyroid Eye Disease: Week 24 Results from the Phase 3 SatraGO-1 and SatraGO-2 Randomized Trials.

Ophthalmology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us